Glasier, Anna F; Cameron, Sharon T; Fine, Paul M; Logan, Susan JS; Casale, William; Van Horn, Jennifer; Sogor, Laszlo; Blithe, Diana L et al. (2010). “Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis”. The Lancet375 (9714): 555–62. doi:10.1016/S0140-6736(10)60101-8. PMID20116841.
Donnez, Jacques; Tatarchuk, Tetyana F.; Bouchard, Philippe; Puscasiu, Lucian; Zakharenko, Nataliya F.; Ivanova, Tatiana; Ugocsai, Gyula; Mara, Michal et al. (2012). “Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery”. New England Journal of Medicine366 (5): 409–20. doi:10.1056/NEJMoa1103182. PMID22296075.
Donnez, Jacques; Vázquez, Francisco; Tomaszewski, Janusz; Nouri, Kazem; Bouchard, Philippe; Fauser, Bart C.J.M.; Barlow, David H.; Palacios, Santiago et al. (2014). “Long-term treatment of uterine fibroids with ulipristal acetate”. Fertility and Sterility101 (6): 1565–73.e1–18. doi:10.1016/j.fertnstert.2014.02.008. PMID24630081.
Courtoy, Guillaume E.; Donnez, Jacques; Marbaix, Etienne; Dolmans, Marie-Madeleine (2015). “In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment”. Fertility and Sterility104 (2): 426–34.e1. doi:10.1016/j.fertnstert.2015.04.025. PMID26003270.
Courtoy, Guillaume E.; Henriet, Patrick; Marbaix, Etienne; de Codt, Matthieu; Luyckx, Mathieu; Donnez, Jacques; Dolmans, Marie-Madeleine (2018-02-01). “Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment”. The Journal of Clinical Endocrinology and Metabolism103 (4): 1566–1573. doi:10.1210/jc.2017-02295. ISSN1945-7197. PMID29408988.
Šauer, Pavel; Stará, Alžběta; Golovko, Oksana; Valentová, Olga; Bořík, Adam; Grabic, Roman; Kocour Kroupová, Hana (2018). “Two synthetic progestins and natural progesterone are responsible for most of the progestagenic activities in municipal wastewater treatment plant effluents in the Czech and Slovak republics”. Water Research137: 64–71. doi:10.1016/j.watres.2018.02.065. PMID29544204.
Šauer, Pavel; Bořík, Adam; Golovko, Oksana; Grabic, Roman; Vojs Staňová, Andrea; Valentová, Olga; Stará, Alžběta; Šandová, Marie et al. (2018). “Do progestins contribute to (anti-)androgenic activities in aquatic environments?”. Environmental Pollution242 (Pt A): 417–425. doi:10.1016/j.envpol.2018.06.104. PMID29990947.
Attardi, Barbara J.; Burgenson, Janet; Hild, Sheri A.; Reel, Jerry R. (2004). “In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone”. The Journal of Steroid Biochemistry and Molecular Biology88 (3): 277–88. doi:10.1016/j.jsbmb.2003.12.004. PMID15120421.
drugs.com
“Ulipristal Acetate”. The American Society of Health-System Pharmacists. 10 December 2017時点のオリジナルよりアーカイブ。8 December 2017閲覧。
ECEC (2014年). “Emergency contraception availability in Europe”. European Consortium for Emergency Contraception (ECEC). 25 March 2014時点のオリジナルよりアーカイブ。25 March 2014閲覧。 “Ulipristal acetate Emergency Contraception Pills (UPA ECPs), while available in most European countries since 2010, are not yet available in Albania, Estonia, Macedonia, Malta, Switzerland and Turkey. For now[いつ?] UPA ECPs are sold with a prescription in all countries, although provision without a prescription is currently[いつ?] being tested in the United Kingdom.”
Glasier, Anna F; Cameron, Sharon T; Fine, Paul M; Logan, Susan JS; Casale, William; Van Horn, Jennifer; Sogor, Laszlo; Blithe, Diana L et al. (2010). “Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis”. The Lancet375 (9714): 555–62. doi:10.1016/S0140-6736(10)60101-8. PMID20116841.
Donnez, Jacques; Tatarchuk, Tetyana F.; Bouchard, Philippe; Puscasiu, Lucian; Zakharenko, Nataliya F.; Ivanova, Tatiana; Ugocsai, Gyula; Mara, Michal et al. (2012). “Ulipristal Acetate versus Placebo for Fibroid Treatment before Surgery”. New England Journal of Medicine366 (5): 409–20. doi:10.1056/NEJMoa1103182. PMID22296075.
Donnez, Jacques; Vázquez, Francisco; Tomaszewski, Janusz; Nouri, Kazem; Bouchard, Philippe; Fauser, Bart C.J.M.; Barlow, David H.; Palacios, Santiago et al. (2014). “Long-term treatment of uterine fibroids with ulipristal acetate”. Fertility and Sterility101 (6): 1565–73.e1–18. doi:10.1016/j.fertnstert.2014.02.008. PMID24630081.
Courtoy, Guillaume E.; Donnez, Jacques; Marbaix, Etienne; Dolmans, Marie-Madeleine (2015). “In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment”. Fertility and Sterility104 (2): 426–34.e1. doi:10.1016/j.fertnstert.2015.04.025. PMID26003270.
Courtoy, Guillaume E.; Henriet, Patrick; Marbaix, Etienne; de Codt, Matthieu; Luyckx, Mathieu; Donnez, Jacques; Dolmans, Marie-Madeleine (2018-02-01). “Matrix metalloproteinase activity correlates with uterine myoma volume reduction after ulipristal acetate treatment”. The Journal of Clinical Endocrinology and Metabolism103 (4): 1566–1573. doi:10.1210/jc.2017-02295. ISSN1945-7197. PMID29408988.
Šauer, Pavel; Stará, Alžběta; Golovko, Oksana; Valentová, Olga; Bořík, Adam; Grabic, Roman; Kocour Kroupová, Hana (2018). “Two synthetic progestins and natural progesterone are responsible for most of the progestagenic activities in municipal wastewater treatment plant effluents in the Czech and Slovak republics”. Water Research137: 64–71. doi:10.1016/j.watres.2018.02.065. PMID29544204.
Šauer, Pavel; Bořík, Adam; Golovko, Oksana; Grabic, Roman; Vojs Staňová, Andrea; Valentová, Olga; Stará, Alžběta; Šandová, Marie et al. (2018). “Do progestins contribute to (anti-)androgenic activities in aquatic environments?”. Environmental Pollution242 (Pt A): 417–425. doi:10.1016/j.envpol.2018.06.104. PMID29990947.
Attardi, Barbara J.; Burgenson, Janet; Hild, Sheri A.; Reel, Jerry R. (2004). “In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone”. The Journal of Steroid Biochemistry and Molecular Biology88 (3): 277–88. doi:10.1016/j.jsbmb.2003.12.004. PMID15120421.
Trussell (13 February 2013). “Dedicated emergency contraceptive pills worldwide”. Office of Population Research at Princeton University, Association of Reproductive Health Professionals. 4 March 2016時点のオリジナルよりアーカイブ。25 March 2014閲覧。
Trussell (13 February 2013). “Dedicated emergency contraceptive pills worldwide”. Office of Population Research at Princeton University, Association of Reproductive Health Professionals. 4 March 2016時点のオリジナルよりアーカイブ。25 March 2014閲覧。
ECEC (2014年). “Emergency contraception availability in Europe”. European Consortium for Emergency Contraception (ECEC). 25 March 2014時点のオリジナルよりアーカイブ。25 March 2014閲覧。 “Ulipristal acetate Emergency Contraception Pills (UPA ECPs), while available in most European countries since 2010, are not yet available in Albania, Estonia, Macedonia, Malta, Switzerland and Turkey. For now[いつ?] UPA ECPs are sold with a prescription in all countries, although provision without a prescription is currently[いつ?] being tested in the United Kingdom.”
